tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RXST Stock Latest News

RxSight’s Earnings Call: Mixed Results Amid Growth and Challenges
Company AnnouncementsRxSight’s Earnings Call: Mixed Results Amid Growth and Challenges
17d ago
RXST
RxSight price target lowered to $11 from $22 at Needham
PremiumThe Fly
RxSight price target lowered to $11 from $22 at Needham
21d ago
RXST
RxSight price target lowered to $8 from $16 at UBS
PremiumThe Fly
RxSight price target lowered to $8 from $16 at UBS
21d ago
RXST
RxSight, Inc. Reports Q2 2025 Financial Results
PremiumCompany Announcements
RxSight, Inc. Reports Q2 2025 Financial Results
21d ago
RXST
RxSight reports Q2 adjusted EPS (8c), consensus (11c)
PremiumThe Fly
RxSight reports Q2 adjusted EPS (8c), consensus (11c)
22d ago
RXST
RxSight sees FY25 revenue $120M-$130M, consensus $126.37M
PremiumThe FlyRxSight sees FY25 revenue $120M-$130M, consensus $126.37M
22d ago
RXST
RxSight Expands Board with New Director Appointment
Premium
Company Announcements
RxSight Expands Board with New Director Appointment
25d ago
8K
RXST
RxSight appoints Raymond Cohen to its board of directors
Premium
The Fly
RxSight appoints Raymond Cohen to its board of directors
25d ago
KMTS
RXST
RxSight Faces Class Action for Alleged Fraud
PremiumClass Action
RxSight Faces Class Action for Alleged Fraud
1M ago
RXST
RxSight downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe Fly
RxSight downgraded to Equal Weight from Overweight at Morgan Stanley
2M ago
RXST
RxSight downgraded to Hold from Buy at Jefferies
PremiumThe Fly
RxSight downgraded to Hold from Buy at Jefferies
2M ago
RXST
Why Is RxSight Stock (RXST) Down 50% Today?
PremiumMarket News
Why Is RxSight Stock (RXST) Down 50% Today?
2M ago
RXST
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
2M ago
AMD
MRK
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
Premium
The Fly
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
2M ago
BA
EXK
RxSight price target lowered to $10 from $18 at Piper Sandler
Premium
The Fly
RxSight price target lowered to $10 from $18 at Piper Sandler
2M ago
RXST
Oppenheimer downgrades RxSight to Perform after preannounced Q2 sales, guidance
PremiumThe Fly
Oppenheimer downgrades RxSight to Perform after preannounced Q2 sales, guidance
2M ago
RXST
RxSight price target lowered to $9 from $18 at BofA
PremiumThe Fly
RxSight price target lowered to $9 from $18 at BofA
2M ago
RXST
RxSight downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
RxSight downgraded to Perform from Outperform at Oppenheimer
2M ago
RXST
RxSight price target lowered to $9 from $17 at Stifel
PremiumThe Fly
RxSight price target lowered to $9 from $17 at Stifel
2M ago
RXST
RxSight downgraded to Neutral from Buy at BTIG
PremiumThe FlyRxSight downgraded to Neutral from Buy at BTIG
2M ago
RXST
RxSight’s Strategic Initiatives and International Expansion Support Buy Rating Amidst Revenue Challenges
Premium
Ratings
RxSight’s Strategic Initiatives and International Expansion Support Buy Rating Amidst Revenue Challenges
2M ago
RXST
RxSight downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
RxSight downgraded to Equal Weight from Overweight at Wells Fargo
2M ago
RXST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >